[ad_1] Drug firm AstraZeneca Pharma India Ltd on Friday (March 7) said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import, sell, and distribute durvalumab (Imfinzi) solution for infusion in 120 mg/2.4 ml and 500 mg/10 ml doses for an additional indication. “This is to inform that AstraZeneca Pharma India […]
AstraZeneca to launch COPD inhaler Breztri Aerosphere in India this January – CNBC TV18
[ad_1] Drug firm AstraZeneca Pharma India Ltd on Monday (November 18) said it has received import and market permission from the Drugs Controller General of India (DCGI) for its inhalation preparation, Breztri Aerosphere, combining budesonide (160mcg), glycopyrronium (7.2mcg), and formoterol fumarate dihydrate (5mcg). “We refer to our earlier communication dated December 2, 2023, intimating the […]